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Exposure of newborn BALB/c mice to murine leukemia virus (MLV) TR1.3 induces fusion of brain capillary endothelial cells (BCEC),
loss of cerebral vessel integrity, hemorrhagic stroke, and death. Although TR1.3 infects endothelial cells in multiple organs, syncytia are only
observed in BCEC. To determine if viral and cellular factors are responsible for selective syncytia formation, capillary endothelial cells
(CEC) from multiple organs were assayed in vitro for MLV infection and cell fusion. Following incubation with virus, all CEC were infected
to an equal extent as determined by expression of MLVenvelope and infectious virus production; however, MLV-induced syncytia were only
observed in TR1.3-infected BCEC cultures. These in vitro results mirror the in vivo pattern of TR1.3 MLV infection and neuropathology, and
definitively show that selective fusion and pathology of BCEC by MLV is determined by properties unique to BCEC as contrasted to other
endothelial cell types.
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IntroductionEndothelial cell damage can lead to the development of
numerous human vascular disorders including atherosclero-
sis, thrombosis, hemorrhage, and sarcoma formation. In
several instances, these changes are linked to, or associated
with, virus infection (Benditt et al., 1983; Fabricant, 1985;
Fish et al., 1998; Lathey et al., 1990; Ross, 1986). For
example, infection of endothelial cells by Human Herpes
Virus 8 is associated with cellular transformation, spindle
cell formation, and the development of Kaposi’s sarcoma
(Boshoff et al., 1995; Chang et al., 1994; Moses et al.,
1999), and infection by human immunodeficiency virus
type-1 (HIV-1) is associated with damage to cerebral vessels0042-6822/$ - see front matter D 2004 Published by Elsevier Inc.
doi:10.1016/j.virol.2003.12.002
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E-mail address: gaulton@mail.med.upenn.edu (G.N. Gaulton).and an increase in the incidence of stroke (Engstrom et al.,
1989; Park et al., 1990; Qureshi et al., 1997). In most
instances, the precise mechanisms responsible for virus-
induced changes in endothelial cell viability and function
are unknown.
Infection of capillary endothelial cells (CEC) is a pre-
requisite of neurological disease in several strains of murine
leukemia virus (MLV), and these viruses have accordingly
been used as modes of human retroviral infections (Czub et
al., 1994; Hoffman et al., 1992; Lynch et al., 1991; Pitts et
al., 1987; Stoica et al., 1993). The induction of neurological
disease by MLV is linked to the capacity of brain capillary
endothelial cells (BCEC) to support virus replication; dis-
ease results from either the direct perturbation of BCEC
function (Masuda et al., 1993; Park et al., 1993) or the
subsequent infection of other cell types within the CNS
(Czub et al., 1994; Masuda et al., 1993; Stoica et al., 1993).
TR1.3 is an acutely neuropathogenic form of Friend MLV
that causes progressive, hemorrhagic stroke in BALB/c
mice (Park et al., 1993, 1994a, 1994b). Exposure of neo-
natal mice to TR1.3 results in infection of CEC in multiple
Fig. 1. Immunofluorescence detection of Factor VIII expression in primary
murine BCEC and KCEC cultures. Primary BCEC (A) and KCEC (B)
cultures were fixed in paraformaldehyde and then incubated with rabbit
antihuman Factor VIII (1:50 dilution). After washing, antibody binding was
detected (magnification, 50) by incubation with FITC-conjugated donkey
anti-rabbit IgG.
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detected within BCEC. Infected BCEC form multinucleated
giant cells, termed syncytia, beginning at 4–7 days of
infection. Syncytia formation both disrupts the integrity of
the blood–brain barrier and initiates thrombogenic events
within brain capillary vessels that lead to the death of
animals at 12–18 days.
The molecular basis of TR1.3-induced syncytia forma-
tion and neurological disease lies in a single tryptophan to
glycine amino acid substitution at residue 102 (W102G)
within the virus envelope (Env) protein. TR1.3 is closely
related by sequence to FB29 MLV, which infects but does
not cause syncytia formation in BCEC (Park et al., 1994a,
1994b). Introduction of the W102G substitution in the
FB29 Env protein is sufficient to reproduce BCEC fusion,
cerebral hemorrhage, and death of BALB/c mice in a
manner indistinguishable from that seen following TR1.3
infection. We recently demonstrated that W102G Env is
inherently more fusigenic than FB29 Env in in vitro cell
fusion assays (Chung et al., 1999). However, because
TR1.3 infects CEC of multiple organs and yet syncytia
are seen only in BCEC (Park et al., 1993, 1994a, 1994b),
cellular factors may also regulate TR1.3-dependent syncytia
formation.
The present studies were initiated to determine whether
BCEC uniquely regulate susceptibility to syncytia formation
and neurological disease. The experimental approach was to
develop an in vitro model of primary mouse CEC cultures
for detailed, comparative analysis of the consequences of
MLV infection. Our results demonstrate that FB29 and
TR1.3 established productive infection and equal levels of
Env expression in all CEC cultures regardless of organ type.
As seen in vivo, FB29 infection did not result in syncytia
formation or other cytopathic effects in any CEC type,
although TR1.3 infection induced syncytia formation and
cell death selectively in BCEC. These results demonstrate
that TR1.3-dependent syncytia formation is a property
unique to BCEC, and establish a working model to dissect
how different CEC types regulate retrovirus-dependent
cytopathology.Results
FB29 and TR1.3 MLV productively infect BALB/c mouse
primary CEC
As a first step in the analysis of TR1.3 cytopathology
for BCEC, we investigated the ability of TR1.3 and FB29
MLV to infect primary capillary endothelial cell cultures
in vitro. Primary cultures of murine CEC were established
from brain, kidney, liver, and lung tissues, and cell purity
was determined by immunohistochemical detection of
Factor VIII expression (Hoffman et al., 1992). As shown
in Fig. 1 for BCEC and KCEC, the expression of Factor
VIII exceeded 95% in CEC primary cultures, and wasuniform in cultures maintained for up to seven passages
in vitro. Similar results were obtained in the analysis of
CEC isolated from liver and lung tissues (data not
shown).
In vitro proliferation of CEC was next determined by
assay of 3H-thymidine incorporation. Although there were
subtle early differences in the proliferation of individual
CEC types, all CEC examined displayed the same extent of
proliferation by 48 h of culture. For example, BCEC
displayed a slightly greater proliferative capacity during
the first 24 h after passage than KCEC (Fig. 2); however,
proliferative capacity from this point onward (up to seven
passages) was not significantly different between these
lines. In view of this, CEC lines were exposed to MLV at
no earlier than 48 h after cell passage.
MLV infection of primary CEC was evaluated by
several criteria including the expression of virus Env
glycoprotein, the production of infectious virus, and the
detection of provirus. Subconfluent CEC cultures were
incubated with either FB29 or TR1.3 MLV at a multiplic-
Fig. 2. Comparison of cellular proliferation in primary BCEC and KCEC
cultures. [3H]-thymidine incorporation of BCEC (diamond symbol) and
KCEC (square symbol)was analyzed at 24, 48, and 72 h following a 6-h pulse
with radiolabel. Each datum point represents the mean F standard error of
the mean (n = 6).
Fig. 4. Production of infectious MLV by BCEC and KCEC in vitro.
Subconfluent BCEC and KCEC cultures were incubated with either TR1.3
or FB29 MLV (MOI = 1.0) and serially passed in vitro. Supernatants were
collected at each passage and titered for virus production by XC-plaque
assay. The data shown are representative of three independent experiments.
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passages in vitro. Expression of virus Env glycoprotein
gp70 was first determined by immunohistochemistry and
flow microfluorimetry. Results shown in Fig. 3 demon-
strate that FB29 and TR1.3 induced an equal level of gp70
expression in BCEC, KCEC, LiCEC, and LuCEC at 48
h of infection. Similar results were obtained in longitudi-
nal analysis of infected CEC at multiple time points over
four passages.
One-time infection growth curves were next generated
from BCEC and KCEC cultures incubated with either
TR1.3 or FB29 to verify that these cells were able toFig. 3. Expression of gp70 virus glycoprotein in infected CEC cultures. CEC prim
(LuCEC) were incubated with either mock virus (striped bar), FB29 (stippled bar)
and flow microfluorimetry. Cells were isolated after 48 h of culture with virus, fix
goat FITC reagent. Values are expressed as Gp70 Mean Channel Fluorescence Fsupport productive virus infection. BCEC and KCEC pro-
duced indistinguishable levels of infectious virus throughout
extended passage in vitro as determined by the XC plaque
assay (Fig. 4). Interestingly, both BCEC and KCEC pro-
duced slightly more virus when infected with FB29 than
with TR1.3. MLV infection of BCEC and KCEC was
confirmed by analysis of genomic DNA using PCR assay
(data not shown).
TR1.3 MLV selectively induces syncytia formation in BCEC
As an approach to understanding the mechanisms that
underlie tissue-specific BCEC cytopathology by TR1.3,ary cultures from brain (BCEC), kidney (KCEC), liver (LiCEC), and lung
, or TR1.3 (hatched bar) and gp70 expression analyzed by immunostaining
ed in paraformaldehyde, and then incubated with goat anti-gp70/rabbit anti-
the standard error of mean from three separate experiments.
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formation in vitro in response to MLV infection. The
capacity of CEC to form syncytia in vitro when infected
by either TR1.3 or FB29 was first examined in long-term
productively infected primary cultures. The presence of
multinucleated giant cell syncytia was observed in TR1.3
infected BCEC cultures by as early as 48 h and persisted
for up to 21 days in culture. A representative sample of
BCEC syncytia induced by TR1.3 is shown in Fig. 5
(arrow). In contrast to this finding, syncytia were not
observed in either KCEC (Fig. 5), or CEC isolated from
either liver or lung tissues (data not shown) when incubated
with TR1.3. The frequency of syncytia formation in these
cultures was 74% in BCEC and <2% in KCEC, LiCEC,
and LuCEC. Lastly, in agreement with previous in vivo
data, syncytia were never observed during FB29 infectionFig. 5. Cell morphology of MLV-infected BCEC and KCEC in vitro. BCEC and
1.0) and passed four times in culture. Cells were then fixed (day 18) in paraformald
Nuclei were stained with DAPI (blue) and visualized under the fluorescence micro
indicated by the arrow. The data are representative of three independent experimof any CEC type (Chung et al., 1999; Park et al., 1993,
1994a).
Although the formation of syncytia in vivo is generally
believed to occur through fusion of infected with uninfected
cells, the inherent capacity of cells to form syncytia can also
be assessed by susceptibility of two uninfected cells to fuse
in the presence of high virus concentrations. Under these
conditions, termed fusion-from-without, virus acts as a
fusion bridge. To perform this analysis, primary BCEC,
KCEC, liver, and lung CEC lines were separately incubated
with virus at an MOI of 100–1000 in the presence of 50
AM AZT to block virus replication. Cultures were then
observed over 24 h for syncytia formation. As shown in
Fig. 6, TR1.3 selectively induced syncytia formation in
BCEC, but not KCEC or other CEC (data not shown). The
frequency of syncytia formation in these cultures was 43%KCEC primary cultures were incubated with either TR1.3 or FB29 (MOI =
ehyde and stained with goat anti-gp70/rabbit anti-goat FITC reagent (green).
scope (magnification, 200). The presence of a multinucleated giant cell is
ents.
Fig. 6. Fusion-from-without in BCEC primary cultures incubated with TR1.3 MLV. Subconfluent monolayers of primary BCEC and KCEC lines were
incubated with concentrated, purified virus or control in the presence of 50 AM AZT for 18 h. Cells were stained with methylene blue and examined
microscopically: magnification BCEC, 200; KCEC, 50. Data shown are representative of three independent experiments. The presence of a multinucleated
giant cell is indicated by the arrow.
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were not observed in any CEC type when incubated with
FB29 MLV.Discussion
TR1.3 infection of BALB/c mice results in syncytia
formation of infected BCEC but not CEC of other organs
(Park et al., 1993). In contrast, exposure of mice to the
closely related virus FB29 does not induce syncytia forma-
tion in any CEC type despite widespread CEC infection.
These observations suggest that syncytia formation is reg-
ulated by properties inherent to both virus and host cell type.
The fusion of virus with cell membranes is a multistep
process (White, 1992). Viral envelope proteins first interact
with receptors on the host cell. In the instance of MLV, this
is believed to occur solely through interaction with the
ecotropic receptor MCAT-1, although accessory compo-
nents have been suggested (Kizhatil and Albritton, 1997;
Siess et al., 1996). The fusion process is initiated by
insertion of the hydrophobic transmembrane domain of
MLV envelope within the cellular plasma membrane (Fasset al., 1997). Membrane mixing occurs when a sufficient
density of multimeric receptor–envelope complexes are
brought into close proximity. The events that govern vi-
rus-mediated cell–cell fusion are less well understood, but
are assumed to follow a similar process.
To examine these cellular properties, we established an in
vitro model of MLV infection in primary CEC. We first
established primary CEC cultures that were 95% pure, as
determined by Factor VIII expression, and that showed the
same rate of cellular proliferation. This is critical in that
MLV is acutely dependent on cell replication for virus
integration. We then examined infection of CEC types using
pathogenic TR1.3 and nonpathogenic FB29 MLV isolates.
Kidney, liver, and lung tissues were chosen for study as
these organs were previously demonstrated to show TR1.3
infection in vivo (Park et al., 1993). All endothelial cells
were productively infected to an equal degree by TR1.3 and
FB29 as determined by viral integration, infectious virus
production, and viral envelope staining. Lastly, direct anal-
ysis of syncytia formation in purified in vitro CEC cultures
was conducted on both productively infected cells and on
uninfected cells using the fusion-from-without assay. In
both instances, syncytia were observed upon infection of
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neither detected in TR1.3 of other CEC types nor were
observed in any CEC type upon infection with the non-
pathogenic MLV FB29. Together these results demonstrate
that the in vitro system defined here recapitulates the virus
and cell selectivity seen during in vivo infection with TR1.3
(Park et al., 1993, 1994a). The results reinforce our pub-
lished results that TR1.3 is inherently more fusigenic than
FB29, and demonstrate that the differential fusion sensitivity
of BCEC to TR1.3 is linked to unique attributes of BCEC.
There are several possible means whereby BCEC may
display enhanced fusion capacity. The level of virus Env
and receptor protein expressed on the plasma membrane
play an important role in regulating the extent of syncytia
formation. In previous studies, we demonstrated that there
was a minimal MCAT-1 receptor threshold level for initia-
tion of fusion, and that this threshold is lower for TR1.3
than FB29 envelope (Chung et al., 1999). We also showed
that the nonpathogenic MLV FB29 mediated cell fusion at a
level equal to that of TR1.3 when envelope and receptor
were overexpressed on target and effector cells, respectively
(Chung et al., 1999). Our analysis here showed that both the
production of infectious TR1.3 and FB29 particles, and
gp70 Env protein expression were similar in infected CEC
lines.
Whether alterations in either receptor levels, accessibil-
ity, or surface distribution contribute to enhanced BCEC
syncytia formation remain interesting possibilities. For ex-
ample, if the absolute amount of MCAT-1 expression on
BCEC is augmented relative to other CEC types, this may
permit syncytia formation by TR1.3 but not FB29, as TR1.3
requires a lower receptor threshold to initiate fusion. Met-
abolic modifications of the MCAT-1 receptor, such as
glycosylation, can also have profound effects on envelope
binding and fusion (Eiden et al., 1994; Miller and Miller,
1992; Wilson and Eiden, 1991), and glycosylation patterns
of MCAT-1 may differ among CEC in different organs.
Lastly, as BCEC form tight junctions and have unique
transport properties, the accessibility and distribution of
receptor on the cell surface may vary among CEC types
(Rubin and Staddon, 1999; Woodard et al., 1994). Irrespec-
tive of receptor levels or posttranslational modification,
BCEC may also possess unique cellular properties that
render them more acutely sensitive to cell fusion. For
example, BCEC may exhibit a distinctive cytoskeletal
organization or membrane composition that promotes either
cell adhesion or fusion (Hildreth and Hampton, 1997;
Wilson et al., 1992). Alternatively, KCEC and other CEC
types may possess a cellular factor that limits membrane
fusion (Siess et al., 1996). We are currently examining each
of these possibilities in CEC isolated from different organs.
In conclusion, this study highlights the establishment of
an in vitro model of TR1.3-induced syncytia formation in
BCEC. With this system, we demonstrated that the selective
in vivo formation of BCEC syncytia during TR1.3 MLV
infection is a unique property of BCEC as contrasted toCEC resident in other tissues. Further insights into the role
of BCEC-specific cellular factors that regulate syncytia
formation are an essential element in understanding virus-
induced neuropathology and neurological disease.Materials and methods
Primary endothelial cell cultures
Primary cultures of CEC were prepared from the brain
(BCEC), kidney (KCEC), liver (LiCEC), and lung (LuCEC)
microvessels of 28-day-old BALB/c mice using a modifi-
cation of a previously defined protocol (Hoffman et al.,
1992). All experiments were performed in accordance with
guidelines using IACUC approved protocols. Briefly, CEC
were grown in minimum essential medium (MEM) with D-
valine (Life Technologies, Inc., Gaithersburg, MD) supple-
mented with 20% fetal calf-serum, L-glutamine (2 mM),
penicillin (50 u/ml), streptomycin (50 Ag/ml), 1/100 volume
of MEM nonessential amino acids solution (Life Technol-
ogies, Inc.), heparin (16 u/ml), and endothelial cell mitogen
(20 Ag/ml) (Biomedical Technologies Inc., Massachusetts).
Aliquots of each primary culture were passed 4–7 times and
examined for purity by expression of Factor VIII using
indirect immunofluorescence. Greater than 95% of CEC
cells in culture expressed Factor VIII.
Endothelial cell growth was measured by thymidine
incorporation, as previously described (Park et al., 1994c).
In brief, 1  102 CEC cells were plated in 96-well plates and
pulsed for 6 h with 1 ACi per well [3H]-thymidine (Dupont
NEN, Waltham, MA) after 24, 48, or 72 h in culture. Cells
were harvested with a PHD harvester (Cambridge Technol-
ogy Inc., Cambridge, MA) and incorporated radiolabel
measured in a liquid scintillation counter.
Virus isolation and infection
The production of FB29, TR1.3, and W102G infectious
virus was previously described (Park et al., 1994c; Sitbon et
al., 1986). In brief, FB29, TR1.3, and W102G are long
terminal repeat-permuted viral DNAs that were cloned into
the modified vector pUC19B. Infectious virus was produced
by gel isolation from pUC19B with HindIII digestion. Virus
was then circularized with T4 DNA ligase and transfected
into the feral mouse embryoblast cell line SC-1 (American
Type Culture Collection, Rockville, MD), using a modified
calcium phosphate transfection procedure as described pre-
viously (Wigler et al., 1979). SC-1 cells were grown in
Dulbecco’s minimal essential medium supplemented with
10% fetal bovine serum and 1% penicillin and streptomycin.
After 1–2 weeks in culture, supernatants were harvested
and assayed for the presence of reverse transcriptase (RT)
activity (Goff et al., 1981). Viral supernatants were ali-
quoted and stored at 80 jC. Viruses were purified by
ultracentrifugation on a 20% sucrose cushion at 19500 rpm
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in DMEM in 10% original volume. Virus titers were
determined by a modified XC cell plaque assay as described
by Rowe et al. (1970).
Endothelial cells were seeded at 1  106 cells per TC-75
flask in 10 ml of media. To initiate virus infection, the
culture media was reduced to 1 ml, supplemented with 4 Ag/
ml polybrene (Sigma Co., St. Louis, MO) for 1 h, and virus
added at an MOI of 1.0 for 1 h at 37 jC. Nine milliliters of
media containing polybrene was then added to each flask
and incubation continued for 24 h. After this time point,
CEC were washed extensively to remove residual virus and
fresh media added. Cultures were subsequently re-fed with
fresh media on days 3 and 6 before passage. Infected and
uninfected cultures were harvested for analysis at time
points indicated in the Results.
Syncytia formation and fusion assay
The formation of cell syncytia in virus infected cultures
was detected by microscopic examination of cell morphol-
ogy after 1–21 days. Cells were fixed in methanol (20 jC
for 3 min) and stained with 0.5% methylene blue in PBS.
Quantification of syncytia was performed by counting cells
in 10 random microscopic fields under 100–400 magni-
fication. Fusion-from-without assays were conducted by
plating CEC in 24 well plates at 1–2  105 cells per well.
After overnight incubation, cells were treated with 50 AM
AZT in media for 12 h. Equivalent amounts of purified
viruses (MOI = 100–1000) were added in the presence of
8 Ag/ml polybrene and allowed to incubate overnight.
Syncytia formation was determined as described above.
The frequency of syncytia formation in cultures was calcu-
lated by dividing the total number of syncytia by the number
of fields counted. A total of 200 fields were counted twice
for each cell line.
Immunohistochemistry
Immunohistochemical detection of virus and cellular
antigens was performed on BCEC and KCEC plated
(0.5–1.0  103 cells/well) on poly-L-lysine coated cover-
slips and fixed in 4% paraformaldehyde for 20 min at room
temperature. Intracellular protein expression in CEC was
performed after fixation in 80% acetone at 20 jC for 5
min. Indirect immunofluorescence was performed after
blocking of coverslips with 5% normal donkey serum
(Jackson ImmunoResearch Labs, West Grove, PA) for 30
min at room temperature. Coverslips were then labeled
with a 0.1% solution of rabbit antihuman Factor VIII
(DAKO Corporation, Carpenteria, CA) and a 0.05% solu-
tion of goat anti-Rauscher gp70 (Quality Biotech Inc.,
Camden, NJ) primary antibodies overnight. Coverslips
were next rinsed with PBS and then incubated with a 1%
solution of either donkey anti-rabbit FITC or TRITC
(Jackson ImmunoResearch Laboratories, Inc., Bar Harbor,ME), or rabbit anti-goat TRITC (Sigma) secondary anti-
bodies for 1 h at room temperature. The coverslips were
next rinsed in PBS, mounted, and sealed before analysis by
fluorescence microscopy.Acknowledgments
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